FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs / Postmarket Safety / Commercial Operations

Baxter Recalls Lot of Injectable Drug

Dec. 3, 2013

Baxter has issued another recall, this time for a single lot of the nitroglycerin 5 percent dextrose injection, a drug used for pre- and post-operative hypertension, congestive heart failure at the onset of heart attack and chest pain in certain patients.

The recall, which comes two months after Baxter recalled two dual luer lock caps, is due to particulates found in a single vial of the injectable drug. The affected lot was distributed to healthcare centers and distributors in Colombia, the U.S. and Saudi Arabia earlier this year.

No other lots or vials are affected and no adverse events have been reported, according to the drugmaker. Baxter spokeswoman Deborah Spak said Monday the company is working closely with the FDA on managing the recall. — Lena Freund

Subscribe to Drug Industry Daily for complete coverage of the pharmaceutical industry. Click here for more information.